CARDIOVASCULAR RISK FEATURES IN PATIENTS WITH METABOLIC-ASSOCIATED FATTY LIVER DISEASE (MAFLD) DEPENDING ON THE PRESENCE OF OBESITY. ijms 2025, 5 (05), 396-403. https://doi.org/10.55640/.